Angiotensin II contributes to activation of Rho in the development of diabetic nephropathy

被引：0
|
作者：
Gojo, A
Utsunomiya, K
Yokota, T
Taniguchi, K
Kurata, H
Kawanami, D
Ishizawa, S
Tajima, N
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A201 / A201
页数：1
相关论文
共 50 条
  • [31] Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy
    Mezzano, S
    Droguett, A
    Burgos, ME
    Ardiles, LG
    Flores, CA
    Aros, CA
    Caorsi, I
    Vío, CP
    Ruiz-Ortega, M
    Egido, J
    KIDNEY INTERNATIONAL, 2003, 64 : S64 - S70
  • [32] Angiotensin II contributes to microglial cell activation in the PVN of hypertensive rats
    Biancardi, Vinicia Campana
    Stern, Javier E.
    FASEB JOURNAL, 2013, 27
  • [33] Angiotensin II Contributes to Renal Fibrosis Independently of Notch Pathway Activation
    Lavoz, Carolina
    Rodrigues-Diez, Raquel
    Benito-Martin, Alberto
    Rayego-Mateos, Sandra
    Rodrigues-Diez, Raul R.
    Alique, Matilde
    Ortiz, Alberto
    Mezzano, Sergio
    Egido, Jesus
    Ruiz-Ortega, Marta
    PLOS ONE, 2012, 7 (07):
  • [34] SPIRONOLACTONE IMPROVING INTRARENAL RENIN-ANGIOTENSIN SYSTEM ACTIVATION IN TYPE II DIABETIC NEPHROPATHY PATIENTS WITH OVERT ALBUMINURIA
    Sawako, Kato
    Shoichi, Maruyama
    Hiroshi, Makino
    Jun, Wada
    Takashi, Uzu
    Hisazumi, Araki
    Daisuke, Koya
    Keizo, Kanasaki
    Akira, Nishiyama
    Enyu, Imai
    Masahiko, Ando
    Seiichi, Matsuo
    NEPHROLOGY, 2014, 19 : 172 - 172
  • [35] Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy
    Andersen, S
    Tarnow, L
    Rossing, P
    Hansen, BV
    Parving, HH
    KIDNEY INTERNATIONAL, 2000, 57 (02) : 601 - 606
  • [36] Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy
    Mima, Akira
    Matsubara, Takeshi
    Arai, Hidenori
    Abe, Hideharu
    Nagai, Kojiro
    Kanamori, Hiroshi
    Sumi, Eriko
    Takahashi, Toshikazu
    Iehara, Noriyuki
    Fukatsu, Atsushi
    Kita, Toru
    Doi, Toshio
    LABORATORY INVESTIGATION, 2006, 86 (09) : 927 - 939
  • [37] COMBINATION OF SYSTEMIC ATRAP DEFICIENCY WITH ANGIOTENSIN II STIMULATION ACCELERATES THE DEVELOPMENT OF DIABETIC NEPHROPATHY IN STREPTOZOTOCIN TREATED MICE
    Taguchi, Shinya
    Azushima, Kengo
    Wakui, Hiromichi
    Suzuki, Toru
    Urate, Shingo
    Abe, Eriko
    Tanaka, Shohei
    Tsukamoto, Shunichiro
    Tamura, Kouichi
    JOURNAL OF HYPERTENSION, 2023, 41 : E375 - E375
  • [38] Effects of specific antagonists of angiotensin II receptors and captopril on diabetic nephropathy in mice
    Yotsumoto, T
    Naitoh, T
    Shikada, K
    Tanaka, S
    JAPANESE JOURNAL OF PHARMACOLOGY, 1997, 75 (01): : 59 - 64
  • [39] Role of angiotensin II and bradykinin in experimental diabetic nephropathy - Functional and structural studies
    Allen, TJ
    Cao, ZM
    Youssef, S
    Hulthen, UL
    Cooper, ME
    DIABETES, 1997, 46 (10) : 1612 - 1618
  • [40] Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns
    Rossing, K
    Mischak, H
    Parving, HH
    Christensen, PK
    Walden, M
    Hillmann, M
    Kaiser, T
    KIDNEY INTERNATIONAL, 2005, 68 (01) : 193 - 205
12345